iZafe Group AB Series B (IZAFE-B) - Total Liabilities

Latest as of September 2025: Skr23.71 Million SEK ≈ $2.55 Million USD

Based on the latest financial reports, iZafe Group AB Series B (IZAFE-B) has total liabilities worth Skr23.71 Million SEK (≈ $2.55 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore IZAFE-B cash flow conversion to assess how effectively this company generates cash.

iZafe Group AB Series B - Total Liabilities Trend (2010–2024)

This chart illustrates how iZafe Group AB Series B's total liabilities have evolved over time, based on quarterly financial data. Check iZafe Group AB Series B (IZAFE-B) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

iZafe Group AB Series B Competitors by Total Liabilities

The table below lists competitors of iZafe Group AB Series B ranked by their total liabilities.

Company Country Total Liabilities
SSR Inc
KQ:275630
Korea ₩3.72 Billion
HPMT Holdings Bhd
KLSE:5291
Malaysia RM27.61 Million
iRobot Corporation
NASDAQ:IRBT
USA $508.46 Million
Aberforth Smaller Companies Trust PLC
LSE:ASL
UK GBX75.31 Million
Georgia Capital PLC
LSE:CGEO
UK GBX3.03 Million
SSP Group PLC
LSE:SSPG
UK GBX3.16 Billion
Copaur Minerals Inc
V:CPAU
Canada CA$182.98K

Liability Composition Analysis (2010–2024)

This chart breaks down iZafe Group AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IZAFE-B stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.29 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.60 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.44 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.59 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how iZafe Group AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for iZafe Group AB Series B (2010–2024)

The table below shows the annual total liabilities of iZafe Group AB Series B from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 Skr14.50 Million
≈ $1.56 Million
+56.59%
2023-12-31 Skr9.26 Million
≈ $996.63K
-21.12%
2022-12-31 Skr11.74 Million
≈ $1.26 Million
+52.55%
2021-12-31 Skr7.70 Million
≈ $828.21K
+36.89%
2020-12-31 Skr5.62 Million
≈ $605.02K
-83.87%
2019-12-31 Skr34.86 Million
≈ $3.75 Million
+4.17%
2018-12-31 Skr33.46 Million
≈ $3.60 Million
+1224.22%
2017-12-31 Skr2.53 Million
≈ $271.95K
-5.55%
2016-12-31 Skr2.68 Million
≈ $287.93K
-27.63%
2015-12-31 Skr3.70 Million
≈ $397.87K
-39.01%
2014-12-31 Skr6.06 Million
≈ $652.40K
+11.88%
2013-12-31 Skr5.42 Million
≈ $583.10K
+4.52%
2012-12-31 Skr5.18 Million
≈ $557.91K
+993.60%
2011-12-31 Skr474.05K
≈ $51.02K
-40.66%
2010-12-31 Skr798.87K
≈ $85.97K
--

About iZafe Group AB Series B

ST:IZAFE-B Sweden Medical Instruments & Supplies
Market Cap
$14.83 Million
Skr137.82 Million SEK
Market Cap Rank
#25880 Global
#542 in Sweden
Share Price
Skr0.38
Change (1 day)
+1.07%
52-Week Range
Skr0.24 - Skr0.72
All Time High
Skr16.60
About

iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also o… Read more